Revcovi
Payments companies reported to CMS as associated with Revcovi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Revcovi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Revcovi
These are the largest totals companies reported as associated with Revcovi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Talal Mousallem | Winston Salem, NC | Pediatric Allergy/Immunology | $22,954.00 |
| Manish Butte | Los Angeles, CA | Pediatric Allergy/Immunology | $14,587.10 |
| Teresa Tarrant | Chapel Hill, NC | Rheumatology | $11,588.50 |
| Morna Dorsey | San Francisco, CA | Pediatric Allergy/Immunology | $9,200.83 |
| Nicholas Hartog | Grand Rapids, MI | Allergy & Immunology | $9,020.13 |
| Aisha Ahmed | Milwaukee, WI | Pediatrics | $7,471.97 |
| Tamara Pozos | Seattle, WA | Pediatric Infectious Diseases | $5,385.00 |
| Luke Wall | New Orleans, LA | Allergy & Immunology | $5,085.00 |
| Jolan Walter | St Petersburg, FL | Pediatric Allergy/Immunology | $4,223.92 |
| William Alexander | Cary, NC | Infectious Disease | $3,600.00 |
Prescribed Revcovi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.